Dextrain, a subsidiary of Medical Devices Venture, expands the Manipulandum application with six new exercises for even more comprehensive dexterity rehabilitation

Paris – May 31, 2023 – Medical Devices Venture announces that its subsidiary Dextrain, a leader in the field of dexterity rehabilitation, is adding new exercises to its Dextrain Manipulandum application. This expansion enables users to benefit from more comprehensive and targeted rehabilitation to improve dexterity and coordination of finger Read more…

Results 2022 and Outlook 2023

Igny, March 23, 2022 – Medical Devices Venture, an investment platform for start-ups developing healthcare solutions, announces its 2022 results and its outlook for 2023. Medical Devices Venture SA’s mission: to help make the home the premier healthcare facility by 2030. Medical Devices Venture invests in start-ups whose objective is Read more…

stane & DOMISANTE, a subsidiary of Medical Devices Venture: two companies with a mission and a common vision of innovation

Paris, March 9, 2023 – Medical Devices Venture announces the partnership of its subsidiary DOMISANTE with stane for revolutionize patient care, enable patients to take charge of their own health, deal with medical deserts and strengthen prevention. stane a created the first French integrated health network. By bringing together innovative Read more…

Roadmap 2023

Paris, January 3, 2022 – The company MEDICAL DEVICES VENTURElaunched in 2021 and listed on the stock exchange since February 2022, aims to invest in Deeptech and MedTech research projects from French research and to accelerate the deployment of start-ups in France and abroad. MEDICAL DEVICES VENTURE already has 4 Read more…

Dextrain, a subsidiary of Medical Devices Venture, starts its Haptics project, winner of a funding from the French National Research Agency

Paris, December 19, 2022 – Dextrain launches its Dextrain-Haptics project in partnership with the Institute of Psychiatry and Neurosciences of Paris. This ambitious project aims at combining haptics with Manipulandum to evaluate and train the tactile sensitivity of fingers. This initiative is supported by ANR funding. Medical Devices Venture announces Read more…

Results to June 30, 2022

Igny, August 8, 2022 – Medical Devices Venture (ISIN: FR0014006PT9 – mnemo: MLMDV), a MedTech investment and acceleration platform, announces its first half 2022 results. Medical Devices Venture SA is the parent company of the Group and is headquartered in Igny, near Paris. Its activity has evolved in 2021 to Read more…